DIN 02241047 — VARILRIX 1995.26231 PFU
VARILRIX is a powder for solution of Varicella-Zoster Virus Live Attenuated marketed by GLAXOSMITHKLINE INC. The full Varicella-Zoster Virus Live Attenuated monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02241047
- Brand name
- VARILRIX
- Active ingredient
- Varicella-Zoster Virus Live Attenuated
- Strength
- 1995.26231 PFU
- Dosage form
- POWDER FOR SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Live attenuated viral vaccine (active immunizing agent against varicella-zoster virus)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.